Service Hospital
Resume:
CURRICULUM VITAE
Dr Belarbia Anis
Nephrology Consultant
Studies
• Secondary: Habib Bourguiba Pioneer School of Tunis
• Academics: Faculty of Medicine "Ibn El Jazzar", Sousse (Tunisia)
• Post-graduate: Faculty of Medicine, Amiens (France).
Professional Experience
2 years of internship
4 years of residency
3 years as specialist in France
11 years’ experience as consultant in Tunisia
MEDICAL STUDIES
- June 1992 - 96: 5 years of medical studies at the Faculty of Medicine of Sousse
- June 1997 - 98: 2-year internship in the Sousse University Hospital (Paediatrics, Orthopaedic Surgery, Haematology, Emergency Services, Gynaecology and Obstetrics).
TRAINING IN THE SPECIALTY OF NEPHROLOGY
In Tunisia
- July 2000 - December 2000: Department of Internal Medicine, Sahloul Teaching Hospital, Sousse
- January 2001 - June 2002: Department of Nephrology, Charles Nicolle Teaching Hospital, Tunis
- July 2002 - September 2002: Department of Cardiology, Farhat Hached Teaching Hospital, Sousse
In Europe
-October 2002 - December 2002: Department of Nephrology, Teaching Hospital of Liege, BELGIUM
- January 2003 - October 2004: Department of Nephrology, Teaching Hospital of Reims, FRANCE
- November 2004 - April 2005: Department of Nephrology, Teaching Hospital of Limoges, FRANCE
DIPLOMAS
-High School diploma: June 1991
-State diploma of PhD of Medicine, Faculty of Medicine of Sousse: September 2002
-Diploma “Theoretical methods of Replacement Renal Treatment and plasmapheresis”, Faculty of Medicine of Amiens, France: July 2004
-Certificate of Speciality (Nephrology): September 2004
-Attending* Certificate or MD: December 2004
(*Attending: instructors or assistant for the medicine school and work fulltime in the hospital)
-Phd: Novembr 2013
-Nephrology consultant: Royal commission hospital (Yanbu) since March 2015.
-Professional Registration ID in SCHS: 15-M-M-0010762
-BLS PROVIDER 09/03/2015
-ACLS PROVIDER 11/01/2016
HOSPITAL AND UNIVERSITY ACTIVITY
After December 2004, we joined the department of Internal Medicine at the hospital of Sahloul for 1 year and 4 months until the official opening of Nephrology Department of Sahloul’s University Hospital.
With the official opening of the department of Nephrology, Dialysis and Renal Transplantation in November 2006, we have actively participated in the start-up of the new department: initially nephrology clinic and hemodialysis, peritoneal dialysis and finally kidney transplantation.
We provide semiology education.
We provide jugular central catheters establishment.
We provide plasma exchange sessions.
We carry out regular kidney biopsies.
We participate in scientific production of the department: research and publications.
We actively participate in various educational seminars and postgraduate education: organized by the Faculty of Medicine of Sousse.
We provide education module of Nephrology in 4th and 5th year at the faculty of medicine.
PUBLICATIONS
1)Epidemiology of hypertension among a population of school children in Sousse, Tunisia.
Imed Harrabi MSc MD1, Anis Belarbia MD2, Rafika Gaha MD1, Ahmed S Essoussi MD3, Hassen Ghannem MSc MD1.
1 Service of Epidemiology, University Hospital Farhat Hached;
2 Service of Internal Medicine, University Hospital Sahloul;
3 Service of Paediatrics, University Hospital Farhat Hached, Sousse, Tunisia.
Can J Cardiol Vol 22 No 3 March 1, 2006.
2)Protective effect of recombinant human erythropoeitin against cisplatin cytotoxicity and genotoxicity in cultured Vero cells
Karima Rjiba-Touatia, Imen Ayed-Boussemaa, Anis Belarbiab, Awatef Azzebibb, Abdellatif Achourb, Hassen Bachaa.
a Laboratory of Research on Biologically Compatible Compounds, Faculty of Dentistry, Monastir University, Monastir, Tunisia
b Department of Nephrology, Dialysis and Transplant, University Hospital of Sahloul, Sousse, Tunisia
Experimental and Toxicologic Pathology 65 (2013) 181–187
3)Protective effect of erythropoietin against cisplatin-induced nephrotoxicity in rats: antigenotoxic and antiapoptotic effect
Karima Rjiba-Touati1, Imen Ayed Boussema1, Chayma Bouaziz1, Anis Belarbia2, Awatef Azzabi2, Abdelatif Achour2, Wafa Hassen1 and Hassen Bacha1.
1 Laboratory of Research on Biologically Compatible Compounds, Faculty of Dentistry, Monastir, Tunisia.
2 Department of Nephrology, Dialysis, and Transplant, University Hospital of Sahloul, Sousse, Tunisia.
Drug and Chemical Toxicology, 2011.
Received 05 January 2011; revised 02 February 2011; accepted 23 March 2011.
Drug Chem Toxicol. 2012 Jan;35(1):89-95
4)Recombinant human erythropoietin prevents cisplatin induced genotoxicity in rat liver and heart tissues via an antioxidant process.
Karima Rjiba-Touati1, Imen Ayed Boussema1, Anis Belarbia2, Abdelatif Achour2 and Hassen Bacha1.
1 Laboratory of Research on Biologically Compatible Compounds, Faculty of Dentistry, Monastir, Tunisia.
2 Department of Nephrology, Dialysis, and Transplant, University Hospital of Sahloul, Sousse, Tunisia.
Drug and Chemical Toxicology, 2011.
Received 09 February 2011; revised 23 March 2011; accepted 29 March 2011.
Drug Chem Toxicol. 2012 Apr;35(2):134-40.
5)The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunction in Wistar rats.
Karima Rjiba-Touati1, Imen Ayed-Boussema1, Anis Belarbia2, Yosra Guedri2, Abdelfatteh Zakhama3, Abdeltif Achour2 and Hassen Bacha1.
1 Laboratory of Research on Biologically Compatible Compounds, Faculty of Dentistry,Monastir, Tunisia.
2 Department of Nephrology, Dialysis and Transplant. University Hospital of Sahloul.Sousse.Tunisia.
3 Department of Anatomic Pathology and Histology. University Hospital of Monastir.Tunisia.
Human & Experimental Toxicology, 2011.
Manuscript ID: HET-11-0214.R2. Date Submitted by the Author: 20-Jul-2011.
Hum Exp Toxicol. 2013 Apr;32(4):407-17.
6) Protective Effect of Recombinant Human Erythropoietin Against Cisplatin-
Induced Oxidative Stress and Nephrotoxicity in Rat Kidney.
Karima Rjiba-Touati1, Imen Ayed Boussema1, Anis Belarbia2, Abdelatif Achour2 and Hassen Bacha1.
1 Laboratory of Research on Biologically Compatible Compounds, Faculty of Dentistry, Monastir, Tunisia.
2 Department of Nephrology, Dialysis and Transplant, University Hospital of
Sahloul, Sousse, Tunisia.
International Journal of Toxicology, 2011.
Reprints and permission: sagepub.com/journalsPermissions.nav. DOI: 10.1177/1091581810411931.
Int J Toxicol. 2011 Oct;30(5):510-7.
7)Hématurie d’effort chez le footballeur à propos de 3 cas et revue de la littérature
A.Zaoui1, A. Belarbia2, W. Ouanes1, S. El Frigui1, F. Khachnaoui1, N. Rejeb1.
1 service de Réeducation fonctionnelle, Hôpital Sahloul, Sousse.
2 Service de Néphrologie, Dialyse et Transplantation rénale, Hôpital Sahloul, Sousse.
Revue Tunisienne de la santé militaire. Sept.2011 ;13:198-200.
8)Induction of DNA fragmentation, chromosome aberrations and micronuclei
by cisplatin in rat bone-marrow cells: Protective effect of recombinant human
Erythropoietin
Karima Rjiba-Touatia, Imen Ayed-Boussemaa, Habib Skhirib, Anis
Belarbiac, Dorsaf Zellemac, Abdelatif Achourcc, Hassen Bachaaa.
a Laboratory of Research on Biologically Compatible Compounds, Faculty of Dentistry, Monastir, Tunisia
b Department of Nephrology, Dialysis and Transplant, University Hospital of Fatouma Bourghuiba, Monastir, Tunisia
c Department of Nephrology, Dialysis and Transplant, University Hospital of Sahloul, Sousse, Tunisia
Mutation Research 747 (2012) 202–206.
9)Hemodialysis duration, Human platelet antigen HPA-3 and IgA Isotype of anti-β2glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients
Samira Hadhria, Mohamed Ben Rejebb, Anis Belarbiac, Abdellatif Achourc, Hadef Skouria
a Laboratoire d’Hématologie et Banque du Sang 03/UR/08-18, CHU Sahloul, 4000, Sousse, Tunisia
b Laboratoire d’Hygiène Hospitalière, CHU Sahloul, 4000, Sousse, Tunisia
c Service de Néphrologie, CHU Sahloul, 4000, Sousse, Tunisia
Thrombosis Research 131 (2013) e202–e209
Adress : TUNISIA : 40 Rue Ezzouhour Msaken 4070 Sousse
Tel : (002**-******** / 73258285
KSA : Nakheel 2 city, Yanbu industrial, A10 number 5
Tel : (009**-*********
Email : *********@*****.*** ********@*****.**
Contact this candidate